Download

Full Text

• Jastrzebski J.T.B.H., and Van Koten G. Penicillins. In: Katritzky A.R. (Ed). Comprehensive Heterocyclic Chemistry (CHC II). 2nd ed. (1995), Elsevier, Oxford, UK 623-658 [Chapter 1.20]
• Hubschwerlen C. β-lactam antibiotics. In: Taylor J.B., and Triggle D.J. (Eds). Comprehensive Medicinal Chemistry. 2nd ed. (2007), Elsevier, Oxford, UK 479-517 [Chapter 7.17]
• Marchand-Brynaert J., and Brulé C. Penicillins. [Chapter 2.03]. In: Katritzky A.R., Ramsden C.A., Scriven E.F.V., and Taylor R.J.K. (Eds). Comprehensive Heterocyclic Chemistry (CHC III). 3rd ed. (2008), Elsevier, Oxford, UK 173-237
• Woodward R.B. Philos. Trans. R Soc. London (B) Biol. Sci. 289 (1980) 239
• Cohen N.C. J. Med. Chem. 26 (1983) 259
• Sweet R.M., and Dahl L.F. J. Am. Chem. Soc. 92 (1970) 5489
• Burton G. Bioorg. Med. Chem. Lett. 3 (1993) 2329
• Mujika J.I., Mercero J.M., and Lopez X. J. Am. Chem. Soc. 127 (2005) 4445
• Clayden J., and Moran W.J. Angew. Chem. Int. Ed. 45 (2006) 7118
• Ren X.-F., Konaklieva M.I., Shi H., Dickey S., Lim D.V., Gonzalves J., and Turos E. J. Org. Chem. 63 (1998) 8898
• Alcaide B., Almendros P., Aragoncillo C., Redondo M.C., and Rosario Torres M. Chem-Eur. J. 12 (2006) 1539
• Jungheim L.N., Boyd D.B., Indelicato J.M., Pasini C.E., Preston D.A., and Alborn Jr. W.E. J. Med. Chem. 34 (1991) 1732
• Baldwin J.E., Lynch G.P., and Pitlik J. J. Antibiot. 44 (1991) 1
• Buynak J.D., Srinivasa Rao A., Adam G., Nidamarthy S.D., and Zhang H. J. Am. Chem. Soc. 120 (1998) 6846
• Williams R.M., Lee B.H., Miller M.M., and Anderson O.P. J. Am. Chem. Soc. 111 (1989) 1073
• Aszodi J., Rowlands D.A., Mauvais P., Collette P., Bonnefoy A., and Lampilas M. Bioorg. Med. Chem. Lett. 14 (2004) 2489
• Berks A.H. Tetrahedron 52 (1996) 331
• Furstner A. Angew. Chem. Int. Ed. 39 (2000) 3012
• Trnka T.M., and Grubbs R.H. Acc. Chem. Res. 34 (2001) 18
• This strategy has been already applied for the preparation of 1,4-fused ring β-lactams. See for examples:. Barrett A.G., Baugh S.P.D., Braddock D.C., Flack K., Gibson V.C., Giles M.R., Marshall E.L., Procopiou P.A., White A.J.P., and Williams D.J. J. Org. Chem. 63 (1998) 7893
• Tarling C.A., Holmes A.B., Markwell R.E., and Pearson N.D. J. Chem. Soc. Perkin Trans. 1 (1999) 1695
• Barrett A.G., Ahmed M., Baker S.P., Baugh S.P.D., Braddock D.C., Procopiou P.A., White A.J.P., and Williams D.J. J. Org. Chem. 65 (2000) 3716
• Desroy N., Robert-Peillard F., Toueg J., Hénaut C., Duboc R., Rager M.-N., Savignac M., and Genêt J.-P. Synthesis 16 (2004) 2665
• For HLE (human leucocyte elastase) inhibitors, see for examples:. Burnett D.A. Curr. Med. Chem. 11 (2004) 1873
• Macchia B., Gentili D., Macchia M., Mamone F., Martinelli A., Orlandini E., Rossello A., Cercignani G., Pierotti R., Allegretti M., Asti C., and Caselli G. Eur. J. Med. Chem. 35 (2000) 53
• Finke P.E., Shah S.K., Fletcher D.S., Ashe K.M., Maycock A.L., Osinga D.G., Underwood D.J., Weston H., Davies P., and Doherty J.B. J. Med. Chem. 38 (1995) 2449
• Underwood D.J., Green B.G., Chabin R., Mills S., Doherty J.B., Finke P.E., Mc Coss M., Shah S.K., Burgey C.S., Dickinson T.A., Griffin P.R., Lee T.E., Swiderek K.M., Covey T., Westler W.M., and Knight W.B. Biochemistry 34 (1995) 14344
• Shah S.K., Dorn Jr. C.P., Finke P.E., Hale J.J., Hagmann W.K., Brause K.A., Chandler G.O., Kissinger A.L., Ashe B.M., Weston H., Knight W.B., Maycock A.L., Dellea P.S., Fletcher D.S., Hand K.M., Mumford R.A., Underwood D.J., and Doherty J.B. J. Med. Chem. 35 (1992) 3745
• see for examples:. Yoakim C., Ogilvie W.W., Cameron D.R., Chabot C., Guse I., Haché B., Naud J., O'Meara J.A., Plante R., and Déziel R. J. Med. Chem. 41 (1998) 2882 For HCMV (human cytomegalovirus) protease inhibitors
• Déziel R., and Malenfant E. Bioorg. Med. Chem. Lett. 8 (1998) 1437
• Bonneau P.R., Hasani F., Plouffe C., Malenfant E., LaPlante S.R., Guse I., Ogilvie W.W., Plante R., Davidson W.C., Hopkins J.L., Morelock M.G., Cordingley M.G., and Déziel R. J. Am. Chem. Soc. 121 (1999) 2965
• For PSA (prostate specific antigen) inhibitors, see for examples:. Adlington R.M., Baldwin J.E., Chen B., Cooper S.L., Mc Coull W., and Pritchard G.J. Bioorg. Med. Chem. Lett. 7 (1997) 1689
• Adlington R.M., Baldwin J.E., Becker G.W., Chen B., Chen L., Cooper S.L., Hermann R.B., Mc Coull W., Mc Nulty A.N., Neubauer B.L., and Pritchard G.J. J. Med. Chem. 44 (2001) 1491
• For human chymase inhibitors, see for example:. Aoyama Y., Uenaka M., Kii M., Tanaka M., Konoike T., Hayasaki-Kajiwara Y., Noya N., and Nokajima M. Bioorg. Med. Chem. 9 (2001) 3065
• Corey E.J., and Venkateswarlu A. J. Am. Chem. Soc. 94 (1972) 6190
• Murakami M., Aoki T., and Nagata W. Heterocycles 30 (1990) 567
• Ahn Y.M., Yang K., and Georg G.I. Org. Lett. 3 (2001) 1411
• Wagner A., Flaig R., Dittrich B., Schmidt H., Koritsanszky T., and Luger P. Chem. Eur. J. 10 (2004) 2977
• Dapporto P., Paoli P., Rossi P., Altamura M., and Perrotta E. Struct. Chem. 10 (1999) 311
• Lopez R., Menendez M.I., Diaz N., Suarez D., Campomanes P., Ardura D., and Sordo T.L. Curr. Org. Chem. 10 (2006) 805 and references cited therein
• Pitarch J., Ruiz-Lopez M.F., Pascual-Ahuir J.L., Silla E., and Tunon I. J. Phys. Chem. B. 101 (1997) 3581
• Olmstead W.N., and Brauman J.I. J. Am. Chem. Soc. 99 (1977) 4219
• Frau J., Donoso J., Munoz F., and Garcia Blanco F. Helv. Chim. Acta 80 (1997) 739
• Massova I., and Kollman P.A. J. Phys. Chem. B. 103 (1999) 8628
• Page M.I. Adv. Phys. Org. Chem. 23 (1987) 165
• Page M.I. Acc. Chem. Res. 17 (1984) 144
• Tsang W.I., Ahmed N., Hemming K., and Page M.I. Can. J. Chem. 83 (2005) 1432
• Pitarch J., Ruiz-Lopez M.F., Silla E., Pascual-Ahuir J.L., and Tunon I. J. Am. Chem. Soc. 120 (1998) 2146
• Dive G., Dehareng D., and Peeters D. Int. J. Quant. Chem. 58 (1996) 85
• Gérard S., Galleni M., Dive G., and Marchand-Brynaert J. Bioorg. Med. Chem. 12 (2004) 129 and references cited therein
• Dive G., and Dehareng D. Int. J. Quant. Chem. 73 (1999) 161
• The reactive species have been calculated at the Hartree-Fock level as the sum of the energies of the isolated partners, and not as a pre-complex moving toward the transition state. Accordingly, the sum of entropies of isolated partners is significantly more higher than the entropy of an intermediate complex and this leads to an over-estimation of the free energy differences.
• Page M.I. The mechanism of reactions of β-lactams. [Chapter 4]. In: Page M.I. (Ed). The Chemistry of β-Lactams (1992), Blackie Academic and Professional, London 129-147
• Matagne A., Lamotte-Brasseur J., and Frère J.M. Biochem. J. 330 (1998) 581
• Frère J.M., Nguyen-Distèche M., Coyette J., and Joris B. Mode of action: interaction with the penicillin binding proteins. [Chapter 5]. In: Page M.I. (Ed). The Chemistry of β-Lactams (1992), Blackie Academic and Professional, London 148-197
• Finke P.E., Ashe B.M., Knight W.B., Maycock A.L., Navia M.A., Shah S.K., Thompson K.R., Underwood D.J., Weston H., Zimmerman M., and Doherty J.B. J. Med. Chem. 33 (1990) 2522
• Maiti S.N., Woods D.E., and Cantin A.M. Drugs Future 6 (1998) 635
• Beauve C., Tjoens G., Touillaux R., Lamotte-Brasseur J., Marchand-Brynaert J., and Fastrez J. Eur. J. Org. Chem. (1999) 1441
• Gérard S., Nollet G., Vande Put J., and Marchand-Brynaert J. Bioorg. Med. Chem. 10 (2002) 3955
• Gérard S., Dive G., Clamot B., Touillaux R., and Marchand-Brynaert J. Tetrahedron 58 (2002) 2423
• Vergely I., Bogetto N., Okochi V., Golpayegani S., Reboud-Ravaux M., Kobaiter R., Joyeau R., and Wakselman M. Eur. J. Med. Chem. 30 (1995) 199
• Cvetovich R.J., Chartain M., Hartner F.W., Roberge Jr. C., Amato J.S., and Grabowski E.J.J. J. Org. Chem. 61 (1996) 6575
• Sauvage E., Herman R., Petrella S., Duez C., Bouillenne F., Frère J.M., and Charlier P. J. Biol. Chem. 280 (2005) 31249
• Fonzé E., Vermeire M., Nguyen-Distèche M., Brasseur R., and Charlier P. J. Biol. Chem. 274 (1999) 21853
• Macheboeuf P., Contreras-Martel C., Job V., Dideberg O., and Dessen A. FEMS Microbiol. Rev. 30 (2006) 673
• Wilke M.S., Lovering A.L., and Strydnaka N.C.J. Curr. Opin. Microbiol. 8 (2005) 525
• Poole K. Cell. Mol. Life Sci. 61 (2004) 2200
• Enright M.C., Robinson D.A., Randle G., Feil E.J., Grundmann H., and Spratt B.G. Proc. Nat. Acad. Sci. USA 99 (2002) 7687
• Lim D., and Strynadka N.C. Nat. Struct. Biol. 9 (2002) 870
• Sauvage E., Kerff F., Fonzé E., Herman R., Schoot B., Marquette J.-P., Taburet Y., Prevost D., Dumas J., Leonard G., Stefanic P., Coyette J., and Charlier P. Cell. Mol. Life Sci. 59 (2002) 1223
• Dessen A., Mouz N., Gordon E., Hopkins J., and Dideberg O. J. Biol. Chem. 276 (2001) 45106
• Carapito R., Chesnel L., Vernet T., and Zapun A. J. Biol. Chem. 281 (2005) 1771
• Pernot L., Chesnel L., Le Gouellec A., Croizé J., Vernet T., Dideberg O., and Dessen A. J. Biol. Chem. 279 (2004) 16463
• Kurazono M., Ida T., Yamada K., Hirai Y., Maruyama T., Shitara E., and Yonezawa M. Antimicrob. Agents Chemother. 48 (2004) 2831
• Sader H.S., Fritsche T.R., Kaniga K., Ge Y., and Jones R.N. Antimicrob. Agents Chemother. 49 (2005) 3501
• Plantan I., Selic L., Mesar T., Anderluh P.S., Oblak M., Prezelj A., Hesse L., Andrejasic M., Vilar M., Turk D., Kocijan A., Prevec T., Vilfan G., Kocjan D., Copar A., Urleb U., and Solmajer T. J. Med. Chem. 50 (2007) 4113
• Waley S.G. β-Lactamase: mechanism of action. [Chapter 6]. In: Page M.I. (Ed). The Chemistry of β-Lactams (1992), Blackie Academic and Professional, London 198-228
• Pratt R.F. β-Lactamase: inhibition. [Chapter 7]. In: Page M.I. (Ed). The Chemistry of β-Lactams (1992), Blackie Academic and Professional, London 229-271
• Spek A.L. PLATON, Molecular Geometry Program (1998), University of Utrecht, The Netherlands
• Sheldrick G.M. SHELXS97 and SHELXL97: Program for the Solution and Refinement of Crystal Structures (1997), University of Göttingen, Germany
• Becke A.D. J. Chem. Phys. 98 (1993) 5648
• Hehre W.J., Ditchfield R., and Pople J.A. J. Chem. Phys. 56 (1972) 2257
• Dive G., Dehareng D., and Ghuysen J.M. Theor. Chim. Acta 85 (1993) 409
• Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Montgomery Jr. J.A., Vreven T., Kudin K.N., Burant J.C., Millam J.M., Iyengar S.S., Tomasi J., Barone V., Mennucci B., Cossi M., Scalmani G., Rega N., Petersson G.A., Nakatsuji H., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Klene M., Li X., Knox J.E., Hratchian H.P., Cross J.B., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J.W., Ayala P.Y., Morokuma K., Voth G.A., Salvador P., Dannenberg J.J., Zakrzewski V.G., Dapprich S., Daniels A.D., Strain M.C., Farkas O., Malick D.K., Rabuck A.D., Raghavachari K., Foresman J.B., Ortiz J.V., Cui Q., Baboul A.G., Clifford S., Cioslowski J., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Martin R.L., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Challacombe M., Gill P.M.W., Johnson B., Chen W., Wong M.W., Gonzalez C., and Pople J.A. Gaussian 03, Revision C.02 (2004), Gaussian, Inc., Wallingford, CT